Evidence map›Paper›PMID 40624432›Full record

ArticleIn vitro cellular & developmental biology. Animal2025

Dexmedetomidine preserves neuronal function by promoting mitochondrial biogenesis through the AMPK/PGC-1α pathway.

Li Wang, Meng Zhang, Shaowei Wang, Zhen Xing, Tong Jia, Xiaojia Sun, Hui Liu, Jie Yao, Yanlin Chen

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Li WangThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Meng ZhangThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Shaowei WangThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Zhen XingThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China. Drxingzheng6218@163.com.ORCID http://orcid.org/0009-0009-8149-0454
Tong JiaThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Xiaojia SunThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Hui LiuThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Jie YaoThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.
Yanlin ChenThe First Clinical Medical College of Hebei North University, No. 36 Changqing Road, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial dysfunction, often linked to the deregulation of mitochondrial biogenesis, plays a significant role in the progression of neurological diseases. Dexmedetomidine (Dex), a selective alpha-2 adrenergic agonist utilized for anesthesia and sedation, has a largely unexplored impact on mitochondrial function. In this study, cells were treated with Dex at concentrations of 10 μg/mL and 20 μg/mL. Mitochondrial function was assessed by measuring mitochondrial membrane potential, adenosine triphosphate (ATP) production, and oxygen consumption rates. The expression levels of key mitochondrial genes and proteins were analyzed using quantitative polymerase chain reaction (qPCR) and Western blot. To investigate the role of AMP-activated protein kinase α (AMPK), cells were co-treated with the AMPK inhibitor Compound C. Our results demonstrate that treating cells with Dex significantly enhances mitochondrial membrane potential, ATP production, and oxygen consumption rates. Additionally, Dex increases the expression of vital mitochondrial genes, including Mitochondrially Encoded NADH: Ubiquinone Oxidoreductase Core Subunit 6 (mtND6), Mitochondrially Encoded Cytochrome c Oxidase II (mtCO2), and Mitochondrially Encoded ATP Synthase 6 (mtATP6), while also improving the mtDNA-to-nDNA ratio. The treatment raises Messenger Ribonucleic Acid (mRNA) and protein levels of essential mitochondrial biogenesis regulators such as Nuclear Respiratory Factor 1(Nrf1), Mitochondrial Transcription Factor A (TFAM), Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1α (PGC-1α), and phosphorylated AMP-Activated Protein Kinase α (p-AMPKα). However, when cells are co-treated with the AMPK inhibitor compound C, these positive effects are lost, highlighting the necessity of AMPK activation for the mitochondrial enhancements induced by Dex. These findings suggest a promising therapeutic potential for Dex in supporting neuronal function through mitochondrial pathways.

Indexed as

AMP-Activated Protein KinasesDexmedetomidineMitochondriaNeuronsOrganelle BiogenesisPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSignal TransductionAdenosine TriphosphateAnimalsDNA, MitochondrialGene Expression RegulationMembrane Potential, MitochondrialOxygen ConsumptionRatsAdenosine TriphosphateAMP-Activated Protein KinasesDexmedetomidineDNA, MitochondrialPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAMPKDexmedetomidineMitochondrial biogenesisMitochondrial DNAPGC-1α

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.